Formulation Compatibility in Natural Health Products

Formulating a natural health product (NHP) involves much more than selecting ingredients that are individually safe, effective, and compliant. Once several medicinal ingredients are combined, they become part of the same chemical and physical environment. Their interactions can influence solubility, stability, appearance, potency, and overall product performance. As a result, a formulation that looks appropriate on paper may behave quite differently once all the ingredients are brought together.

This becomes particularly important when a product contains several botanical extracts, vitamins, minerals, and other bioactive ingredients. Each raw material may meet its individual specification, yet the finished product can develop characteristics that could not have been predicted by evaluating the ingredients separately.

When medicinal ingredients interact

Botanical extracts provide a good example of this complexity. Unlike a purified compound, a botanical extract can contain a wide range of naturally occurring constituents, including polyphenols, flavonoids, tannins, alkaloids, organic acids, sugars, and other compounds. When different extracts are combined, these constituents may interact through mechanisms such as complex formation, adsorption, changes in solubility, or other chemical associations.

One example is the interaction between polyphenol or tannin containing extracts and minerals such as iron. Certain polyphenolic compounds can bind metal ions, which may influence their chemical behaviour and solubility within the formulation. The extent of this interaction depends on the specific ingredients, their concentrations, and the overall formulation environment.

Interactions can also occur between botanical extracts themselves. A formulation may gradually develop changes in colour, turbidity, sedimentation, viscosity, taste, or odour even though each extract was individually stable. These changes can become more noticeable as the concentration and number of medicinal ingredients increase.

Understanding these potential interactions becomes even more important when the formulation contains ingredients that are sensitive to environmental conditions such as oxygen, light, temperature, or pH.

Oxidative Degradation Pathways and Stability Risk

Oxidation is one of the most important chemical stability concerns in formulations containing susceptible vitamins and botanical constituents. Ingredients such as ascorbic acid and various polyphenolic compounds in botanical extracts can participate in oxidation and reduction reactions. In the presence of oxygen, light, heat, or trace metals, these reactions can contribute to gradual colour changes, off odours, loss of potency, or the formation of degradation products.

This concern is particularly relevant for liquid NHPs because ingredients are in close contact within the same formulation. Oxygen present in the formulation or headspace, oxygen entering through the packaging, and trace levels of catalytic metals can all influence the rate at which oxidation occurs.

For this reason, a formulation should be evaluated as a complete system rather than assuming that the stability of each individual ingredient will automatically translate into stability of the finished product.

How pH Shifts Affect Ionization, Solubility, and Precipitation

pH is another important factor that can determine whether medicinal ingredients remain compatible. Different ingredients can have very different pH requirements for optimum stability and solubility. Adjusting the pH to improve the performance of one ingredient may therefore have an unintended effect on another.

For example, an extract that is clear and soluble at one pH may become hazy or precipitate when the pH is changed. The same change can affect the ionization and solubility of organic acids, minerals, and other botanical constituents. In a liquid NHP, this may ultimately result in precipitation, haze, colour changes, changes in viscosity, or a reduction in measurable potency.

Therefore, the target pH should be established based on the behaviour of the complete formulation, rather than being selected solely according to the requirements of one medicinal ingredient.

Specification Compliance vs. Formulation Compatibility

 A Certificate of Analysis demonstrates that a raw material meets its established specification, but it does not necessarily predict how that material will behave after being combined with several other medicinal and non-medicinal ingredients.

Health Canada recognizes a range of factors that can influence NHP stability, including pH, chemical interactions, oxidation and reduction, temperature, humidity, light, oxygen, and other environmental conditions.

Consequently, formulation R&D should be viewed as an important risk assessment stage, not simply as a small-scale version of commercial manufacturing. Before moving to large scale production, formulators should evaluate relevant characteristics such as pH, appearance, colour, odour, solubility, precipitation, viscosity, homogeneity, assay or potency, microbial quality, and, where appropriate, oxidative stability and degradation.

Formulation R&D as a Risk Mitigation Strategy

A well-designed R&D study provides an opportunity to identify potential incompatibilities while the formulation is still relatively easy to modify. Depending on the problem identified, solutions may include adjusting the pH, changing the order of ingredient addition, modifying ingredient concentrations, selecting a different botanical extract, evaluating an antioxidant or chelating strategy, or selecting a more suitable packaging system.

Once the formulation has demonstrated acceptable performance during development, stability testing can provide further insight into how it behaves over time. Stability studies are particularly important because some problems may not become apparent immediately after manufacturing. A product can look, taste, and test satisfactorily at the beginning of its shelf life and still undergo gradual changes during storage.

The key lesson is that a formulation that looks acceptable on Day 1 is not necessarily a stable formulation. What matters is whether the medicinal ingredients remain compatible and whether the product continues to meet its physical, chemical, and microbiological requirements throughout its intended shelf life.

For NHP formulators, investing in R&D and stability testing before large-scale manufacturing is therefore much more than a quality control exercise. It is a practical way to understand how ingredients behave together, identify problems early, reduce manufacturing risk, and help prevent costly batch failures, investigations, reformulation, customer complaints, and potential recalls.

References

1.      Health Canada., Good Manufacturing Practices Guide for Natural Health Products (GUI-0158): Stability Period. Health Canada — NHP GMP Guide

2.      Delimont, N. M., Haub, M. D., & Lindshield, B. L. (2017). The impact of tannin consumption on iron bioavailability and status: A narrative review. Current developments in nutrition, 1(2), 1-12.

3.      Health Canada., Quality of Natural Health Products Guide.

4.      Williamson, G. (2025). Bioavailability of food polyphenols: current state of knowledge. Annual review of food science and technology, 16(1), 315-332.

5.      Yin, X., Chen, K., Cheng, H., Chen, X., Feng, S., Song, Y., & Liang, L. (2022). Chemical stability of ascorbic acid integrated into commercial products: A review on bioactivity and delivery technology. Antioxidants, 11(1), 153.